Wockhardt’s share price surged 6.5% following FDA acceptance of its New Drug Application for Zaynich, marking a significant milestone for Indian pharma. The two-day rally reached nearly 27%, reflecting renewed investor interest and highlighting India’s potential in global antibiotic innovation.
Source :- mint – markets Read More
